Marijuana Moment reported on October 22 that DEA Chief Administrative Law Judge Derek Julius has turned down a request from opponents of marijuana rescheduling to reopen the hearing on the Trump administration’s Schedule III proposal for another round of testimony and document discovery. Julius wrote that some of what the opponents wanted to explore is “immaterial for the narrow purpose of this hearing,” and that other parts “could have been explored” while witnesses were on the stand this summer.
He did give them something. A Government Accountability Office report published last month — which found that DEA “does not have any policies or procedures regarding how its staff are to conduct evaluations or schedule substances,” and that FDA lacks written procedures for developing scheduling recommendations — goes into the record, and the parties may file briefs about how much weight it deserves and whether those gaps touch this particular proposal. Initial filings are invited by October 29, replies by November 5, and the proceeding remains stayed until the briefing window closes.
DEA, which is defending the rescheduling proposal, called the motion to reopen an “obvious fishing expedition based on a Report that is clear on its face,” according to the outlet. The agency’s own final brief argued marijuana “no longer fits the statutory requirements for Schedule I” and asked the judge to recommend the move to Schedule III quickly. Separately, the outlet noted, several consolidated lawsuits over the rescheduling effort are pending before the D.C. Circuit.
“The GAO is not a party to this litigation, and the GAO Report speaks for itself regarding its conclusions on the general rescheduling process and documentation about that process”
DEA Chief Administrative Law Judge Derek Julius
“The proposed rule, the supporting documents, and the Government witnesses will establish that marijuana has a currently accepted medical use”
James Schwartz, DEA attorney
What it means in Oregon
None of this changes anything you can do in Oregon. Adult use, possession and the licensed retail system sit in ORS 475C and in Oregon Liquor and Cannabis Commission rules, and they run on their own terms regardless of where cannabis sits on the federal schedule. A Schedule III reclassification would not make state-licensed sales lawful under federal law; the clearest practical effect for licensees would be on federal taxation, since 26 U.S.C. 280E applies only to Schedule I and II substances.
Where federal status does reach into daily life here is work. As our guide to marijuana and your job in Oregon explains, ORS 475C.013(1) says the Act may not be construed to amend or affect employment law, and the Oregon Supreme Court’s Emerald Steel decision leaned on federal illegality in holding that employers need not accommodate even card-holding medical use. A schedule change alone does not undo either of those, and no Oregon session bill has replaced them.
What to watch: whether briefs land by the October 29 and November 5 deadlines, when Julius issues a recommendation, and what the D.C. Circuit does with the consolidated challenges. Our page on federal law covers where the gap between Salem and Washington actually bites.